Drug Profile
Research programme: malaria vaccines - Paladin Labs
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Paladin Labs
- Developer Endo International
- Class Parasitic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Malaria
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Malaria in Canada (Parenteral)
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
- 23 Oct 2009 Preclinical trials in Malaria in Canada (Parenteral)